Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis.
Abro B, Maurer MJ, Habermann TM, Burack WR, Chapman JR, Cohen JB, Friedberg JW, Inghirami G, Kahl BS, Larson MC, Link BK, Lossos IS, Martin P, McDonnell TJ, Nastoupil LJ, Riska SM, Syrbu S, Vega F, Vij KR, Flowers CR, Cerhan JR, Jaye DL, Feldman AL. Abro B, et al. Among authors: syrbu s. Blood. 2024 Nov 7;144(19):2063-2066. doi: 10.1182/blood.2024025681. Blood. 2024. PMID: 39255410
Evolving frontline immunochemotherapy for mantle cell lymphoma and the impact on survival outcomes.
Castellino A, Wang Y, Larson MC, Maurer MJ, Link BK, Farooq U, Feldman AL, Syrbu SI, Habermann TM, Paludo J, Inwards DJ, Witzig TE, Ansell SM, Allmer C, Slager SL, Cohen JB, Martin P, Cerhan JR, Nowakowski GS. Castellino A, et al. Among authors: syrbu si. Blood Adv. 2022 Feb 22;6(4):1350-1360. doi: 10.1182/bloodadvances.2021005715. Blood Adv. 2022. PMID: 34662895 Free PMC article.
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.
Cerhan JR, Maurer MJ, Link BK, Feldman AL, Habermann TM, Jaye DL, Burack WR, McDonnell TJ, Vega F, Chapman JR, Syrbu S, Vij KR, Inghirami G, Leonard JP, Bernal-Mizrachi L, Farooq U, Witzig TE, Weiner GJ, Wang Y, Alderuccio JP, Slager SL, Larson MC, Riska SM, Gysbers BJ, Lunde JJ, Reicks TW, Ayers AA, O'Leary CB, Yost KJ, Liu H, Nowakowski GS, Ruan J, Chihara D, Koff JL, Casulo C, Thompson CA, Cohen JB, Kahl BS, Nastoupil LJ, Lossos IS, Friedberg JW, Martin P, Flowers CR. Cerhan JR, et al. Among authors: syrbu s. Am J Hematol. 2024 Mar;99(3):408-421. doi: 10.1002/ajh.27202. Epub 2024 Jan 13. Am J Hematol. 2024. PMID: 38217361
The utility of prognostic indices, early events, and histological subtypes on predicting outcomes in non-follicular indolent B-cell lymphomas.
Tracy SI, Larson MC, Feldman AL, Maurer MJ, Novak AJ, Slager SL, Villasboas JC, Allmer C, Habermann TM, Farooq U, Syrbu S, Cerhan JR, Link BK. Tracy SI, et al. Among authors: syrbu s. Am J Hematol. 2019 Jun;94(6):658-666. doi: 10.1002/ajh.25473. Epub 2019 Apr 10. Am J Hematol. 2019. PMID: 30916801 Free PMC article. Clinical Trial.
Causes of death in low-grade B-cell lymphomas in the rituximab era: a prospective cohort study.
Tun AM, Khurana A, Mwangi R, Link BK, Wang Y, Feldman AL, Thompson CA, Novak AJ, Villasboas JC, Thanarajasingam G, Farooq U, Syrbu S, Nowakowski GS, Witzig TE, Ansell SM, Rimsza LM, Cerhan JR, Habermann TM, Maurer MJ. Tun AM, et al. Among authors: syrbu s. Blood Adv. 2022 Sep 13;6(17):5210-5221. doi: 10.1182/bloodadvances.2022007990. Blood Adv. 2022. PMID: 35849723 Free PMC article.
Outcomes among North American patients with diffuse large B-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression.
Tracy SI, Habermann TM, Feldman AL, Maurer MJ, Dogan A, Perepu US, Syrbu S, Ansell SM, Thompson CA, Weiner GJ, Nowakowski GS, Allmer C, Slager SL, Witzig TE, Cerhan JR, Link BK. Tracy SI, et al. Among authors: syrbu s. Haematologica. 2018 Feb;103(2):297-303. doi: 10.3324/haematol.2017.176511. Epub 2017 Nov 23. Haematologica. 2018. PMID: 29170255 Free PMC article.
Prevalence, clinical characteristics and prognosis of EBV-positive follicular lymphoma.
Mackrides N, Chapman J, Larson MC, Ramos JC, Toomey N, Lin P, Maurer MJ, Rafaelle M, Tan Y, Ikpatt O, Syrbu S, Ansell SM, Habermann TM, Link BK, Feldman AL, Lossos IS, Cerhan JR, Vega F. Mackrides N, et al. Among authors: syrbu s. Am J Hematol. 2019 Feb;94(2):E62-E64. doi: 10.1002/ajh.25357. Epub 2018 Dec 5. Am J Hematol. 2019. PMID: 30474261 Free PMC article. No abstract available.
Recurrent MSC E116K mutations in ALK-negative anaplastic large cell lymphoma.
Luchtel RA, Zimmermann MT, Hu G, Dasari S, Jiang M, Oishi N, Jacobs HK, Zeng Y, Hundal T, Rech KL, Ketterling RP, Lee JH, Eckloff BW, Yan H, Gaonkar KS, Tian S, Ye Z, Kadin ME, Sidhu J, Jiang L, Voss J, Link BK, Syrbu SI, Facchetti F, Bennani NN, Slager SL, Ordog T, Kocher JP, Cerhan JR, Ansell SM, Feldman AL. Luchtel RA, et al. Among authors: syrbu si. Blood. 2019 Jun 27;133(26):2776-2789. doi: 10.1182/blood.2019000626. Epub 2019 May 17. Blood. 2019. PMID: 31101622 Free PMC article.
Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma.
Mondello P, Fama A, Larson MC, Feldman AL, Villasboas JC, Yang ZZ, Galkin I, Svelolkin V, Postovalova E, Bagaev A, Ovcharov P, Varlamova A, Huet S, Tesson B, McGrath KR, Slager S, Link BK, Syrbu S, Novak AJ, Habermann TM, Witzig TE, Nowakowski GS, Salles G, Cerhan JR, Ansell SM. Mondello P, et al. Among authors: syrbu s. Blood Cancer J. 2021 Jul 15;11(7):130. doi: 10.1038/s41408-021-00521-4. Blood Cancer J. 2021. PMID: 34267181 Free PMC article.
72 results